ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Neurovascular Devices for Ischemic Stroke Market 2020-2025 Featuring Abbott, Boston Scientific, Cardinal Health, Penumbra, Stryker, Terumo, and More - ResearchAndMarkets.com

October 8, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Oct 8, 2021--

The “Global Neurovascular Devices for Ischemic Stroke Market” report has been added to ResearchAndMarkets.com’s offering.

This report covers the impact of COVID-19 on the neurovascular devices for ischemic stroke market, including a recent forecast from 2020 to 2025.

COVID-19 also impacted leading competitors, such as Abbott, Boston Scientific, Cardinal Health, Penumbra, Stryker, Terumo, and others. The report provides insights into trends, drivers, and limiters of the neurovascular devices for ischemic stroke market, as well as highlights potential opportunities.

ADVERTISEMENT

Information covered by this report includes:

  • Unit volumes & pricing forecast from 2020-2025,
  • Analyses of the leading companies, and
  • Global market share analysis.

Companies Mentioned

  • Abbott
  • Boston Scientific
  • Cerenovus/J&J
  • Concentric/Stryker
  • Cordis Cardinal Health
  • InNeuroCo
  • Micropo
  • Penumbra
  • Terumo Microvention

For more information about this report visit https://www.researchandmarkets.com/r/z0p7m0

View source version on businesswire.com:https://www.businesswire.com/news/home/20211008005123/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 10/08/2021 04:49 AM/DISC: 10/08/2021 04:49 AM

http://www.businesswire.com/news/home/20211008005123/en